Vland Biotech's subsidiary receives registration certificates for two joint applications of new veterinary drugs

Zhitong
2025.09.17 07:44
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Vland Biotech announced that, after review by the Ministry of Agriculture and Rural Affairs, the company's wholly-owned subsidiary Qingdao Kangdien Animal Pharmaceutical Co., Ltd. and other units jointly applied for "Fluralaner Drops (for Dogs)" and "Fluralaner Drops (for Cats)" to be classified as new veterinary drugs of Category II, and the "New Veterinary Drug Registration Certificate" was recently issued

According to the announcement from Zhitong Finance APP, Vland Biotech (603739.SH) stated that, after review by the Ministry of Agriculture and Rural Affairs, the company's wholly-owned subsidiary Qingdao Kangdian Animal Pharmaceutical Co., Ltd. has jointly applied with other units for the "Fluralaner Drops (for Dogs)" and "Fluralaner Drops (for Cats)" to be classified as Category II new veterinary drugs, and the "New Veterinary Drug Registration Certificate" was recently issued

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer